WMG Financial Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Sell |
10,820
-2,075
| -16% | -$53.2K | 0.1% | 143 |
|
|
2025
Q1 | $354K | Sell |
12,895
-398
| -3% | -$10.9K | 0.15% | 94 |
|
|
2024
Q4 | $358K | Sell |
13,293
-93
| -0.7% | -$2.51K | 0.15% | 98 |
|
|
2024
Q3 | $386K | Hold |
13,386
| – | – | 0.17% | 82 |
|
|
2024
Q2 | $365K | Sell |
13,386
-2,153
| -14% | -$58.7K | 0.19% | 77 |
|
|
2024
Q1 | $435K | Sell |
15,539
-1,539
| -9% | -$43.1K | 0.25% | 73 |
|
|
2023
Q4 | $455K | Sell |
17,078
-79
| -0.5% | -$2.1K | 0.3% | 65 |
|
|
2023
Q3 | $439K | Sell |
17,157
-22,036
| -56% | -$563K | 0.37% | 57 |
|
|
2023
Q2 | $1.03M | Sell |
39,193
-12,266
| -24% | -$321K | 0.76% | 29 |
|
|
2023
Q1 | $1.34M | Buy |
51,459
+11,386
| +28% | +$297K | 1.11% | 24 |
|
|
2022
Q4 | $1.1M | Sell |
40,073
-1,894
| -5% | -$52K | 0.94% | 31 |
|
|
2022
Q3 | $1.01M | Buy |
41,967
+9,800
| +30% | +$235K | 0.91% | 33 |
|
|
2022
Q2 | $848K | Buy |
+32,167
| New | +$848K | 0.74% | 38 |
|